MoneyWorks4Me

Agnus Capital LLP submits disclosure

21 Mar 2018 Evaluate

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agnus Capital LLP.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.90
Dr. Reddys Labs. 1237.10
Cipla 1327.15
Lupin 1932.00
Zydus Lifesciences 1127.50
View more..